Physician profile
Frieda M Menzer
NPI 1801996285
$743.50
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $166.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $137.59 | 2019-2020 | |
| Astellas Pharma US INC | $125.75 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.73 | 2019-2020 | |
| Glaxosmithkline, LLC. | $68.46 | 2019-2020 | |
| Novo Nordisk INC | $49.35 | 2019-2020 | |
| Amgen INC. | $46.60 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $46.17 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.23 | 2019-2020 | |
| Abbvie INC. | $29.14 | 2019-2020 | |
| Amarin Pharma, INC. | $24.15 | 2019 | |
| Boston Scientific Corporation | $19.90 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.53 | 2019 | |
| Ironwood Pharmaceuticals, INC | $14.96 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.54 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.98 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.87 | 2019 | |
| Shire North American Group INC | $11.55 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frieda Menzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.